| Generic Name: | felbamate |
| Company: | Meda Pharmaceuticals Inc. |
| Web Site: | www.felbatol.com/ |
| Country: | USA |
| |
 |
Description: |
Felbatol (felbamate) is an antiepileptic available as 400 mg and 600 mg tablets and as a 600 mg/5 mL suspension for oral administration. Its chemical name is 2-phenyl-1,3-propanediol dicarbamate. |
| |
| Indications: | Felbatol is not indicated as a first line antiepileptic treatment. Felbatol is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use.
Revised April 2009 |
| |
| |
| |
